omniture
logo
Search
德琪（浙江）医药科技有限公司 Deqi (zhejiang) Pharmaceutical Technology Co. LTD
Media Room

Latest News

rss

Antengene's New Drug Discovery Center Established in Zhangjiang, Shanghai: Dedicated to the Research and Development of Innovative Therapies for Cancer

SHANGHAI, Oct. 12, 2020 /PRNewswire/ -- Antengene Corporation, a leading innovative biopharmaceutic...

2020-10-12 20:00 4516
Antengene's New Drug Discovery Center Established in Zhangjiang, Shanghai: Dedicated to the Research and Development of Innovative Therapies for Cancer

Australian Therapeutic Goods Administration Approves the First Phase I Trial of ATG-017 for the Treatment of Patients with Advanced Solid Tumors and Hematological Malignancies

SHANGHAI and MELBOURNE, Australia, Aug. 13, 2020 /PRNewswire/ -- Antengene Corporation, a leading i...

2020-08-13 06:00 2432

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, July 20, 2020 /PRNewswire/ -- Antengene Corporation, a leading innovative hematology and ...

2020-07-20 08:00 8498
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

Antengene Appoints Former Celgene ANZ Medical Leader Dirk Hoenemann as Head of Medical Affairs in Asia Pacific Region & Early Clinical Development

SHANGHAI and MELBOURNE, Australia, July 13, 2020 /PRNewswire/ -- Antengene Corporation (Antengene) ...

2020-07-13 06:00 3964
Antengene Appoints Former Celgene ANZ Medical Leader Dirk Hoenemann as Head of Medical Affairs in Asia Pacific Region & Early Clinical Development

­Antengene Corporation Appoints Former BMS Senior Leader of Biostatistics Zhinuan YU as Corporate Vice President of Biometrics and Regulatory Enabling Functions

SHANGHAI and PHILADELPHIA, July 1, 2020 /PRNewswire/ --Antengene Corporation today announced its a...

2020-07-02 08:16 1328
­Antengene Corporation Appoints Former BMS Senior Leader of Biostatistics Zhinuan YU as Corporate Vice President of Biometrics and Regulatory Enabling Functions

Antengene Corporation Appoints Mr. Donald Lung as Chief Financial Officer

SHANGHAI and HONG KONG, June 8, 2020 /PRNewswire/ -- Antengene Corporation (Antengene) today announ...

2020-06-08 20:00 1990
Antengene Corporation Appoints Mr. Donald Lung as Chief Financial Officer

Antengene Announces Expansion of Partnership with Karyopharm in Asia Pacific Markets

SHANGHAI, May 5, 2020 /PRNewswire/ -- Antengene Corporation (Antengene) today announced a broaden...

2020-05-05 20:30 1846

Antengene Announces Dosing of First Patient in the ATG-019 (KPT-9274) Phase 1 Trial, a First-in-Class Dual Inhibitor, for Advanced Solid Tumors and Non-Hodgkin's Lymphoma

SHANGHAI and PHILADELPHIA, April 14, 2020 /PRNewswire/ -- Antengene announced today that it has dos...

2020-04-14 21:15 1340

Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions

SHANGHAI and MELBOURNE, Australia, April 13, 2020 /PRNewswire/ -- Antengene Corporation today annou...

2020-04-13 20:00 3025
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions

Former Celgene Chairman and CEO Mark J. Alles Joins Antengene Board of Directors

SHANGHAI and PHILADELPHIA, Jan. 8, 2020 /PRNewswire/ -- The Antengene board today announced the app...

2020-01-08 20:00 2819

Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer

SHANGHAI and PHILADELPHIA, Jan. 6, 2020 /PRNewswire/ -- Antengene Corporation today announced its a...

2020-01-06 20:00 3090
Antengene Corporation Appoints Former Celgene China GM John Chin as Chief Business Officer

Antengene Corporation Announces Exclusive Worldwide License to Develop and Commercialize AZD0364

SHANGHAI and LONDON, Nov. 7, 2019 /PRNewswire/ -- Antengene Corporation today announced that it has...

2019-11-07 01:40 2275
1 ... 45678